TIAA CREF Investment Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $892K | Hold |
29,499
| – | – | ﹤0.01% | 2377 |
|
2018
Q4 | $991K | Sell |
29,499
-1,601
| -5% | -$53.8K | ﹤0.01% | 2281 |
|
2018
Q3 | $1.31M | Sell |
31,100
-1,037
| -3% | -$43.7K | ﹤0.01% | 2323 |
|
2018
Q2 | $1.03M | Sell |
32,137
-2,098
| -6% | -$67.1K | ﹤0.01% | 2485 |
|
2018
Q1 | $1.7M | Sell |
34,235
-1,766
| -5% | -$87.8K | ﹤0.01% | 2185 |
|
2017
Q4 | $1.94M | Sell |
36,001
-2,416
| -6% | -$130K | ﹤0.01% | 2154 |
|
2017
Q3 | $2.23M | Sell |
38,417
-942
| -2% | -$54.6K | ﹤0.01% | 2111 |
|
2017
Q2 | $1.94M | Sell |
39,359
-7,532
| -16% | -$372K | ﹤0.01% | 2197 |
|
2017
Q1 | $2.04M | Sell |
46,891
-6,629
| -12% | -$288K | ﹤0.01% | 2138 |
|
2016
Q4 | $2.62M | Sell |
53,520
-1,778
| -3% | -$87K | ﹤0.01% | 2032 |
|
2016
Q3 | $2.65K | Buy |
55,298
+10,535
| +24% | +$504 | ﹤0.01% | 2023 |
|
2016
Q2 | $2.4M | Sell |
44,763
-2,165
| -5% | -$116K | ﹤0.01% | 2001 |
|
2016
Q1 | $2.1M | Sell |
46,928
-2,195
| -4% | -$98.2K | ﹤0.01% | 2040 |
|
2015
Q4 | $1.88M | Sell |
49,123
-23,750
| -33% | -$907K | ﹤0.01% | 2195 |
|
2015
Q3 | $2.32M | Sell |
72,873
-23,140
| -24% | -$737K | ﹤0.01% | 2050 |
|
2015
Q2 | $3.17M | Buy |
96,013
+1,942
| +2% | +$64.1K | ﹤0.01% | 1999 |
|
2015
Q1 | $3.87M | Sell |
94,071
-12,244
| -12% | -$504K | ﹤0.01% | 1807 |
|
2014
Q4 | $4.33M | Sell |
106,315
-3,050
| -3% | -$124K | ﹤0.01% | 1725 |
|
2014
Q3 | $4.01M | Sell |
109,365
-1,402
| -1% | -$51.4K | ﹤0.01% | 1771 |
|
2014
Q2 | $5.13M | Buy |
110,767
+4,746
| +4% | +$220K | ﹤0.01% | 1681 |
|
2014
Q1 | $4.36M | Buy |
106,021
+3,865
| +4% | +$159K | ﹤0.01% | 1717 |
|
2013
Q4 | $3.9M | Buy |
102,156
+24,519
| +32% | +$936K | ﹤0.01% | 1817 |
|
2013
Q3 | $1.86M | Buy |
77,637
+8,847
| +13% | +$212K | ﹤0.01% | 2246 |
|
2013
Q2 | $1.17M | Buy |
+68,790
| New | +$1.17M | ﹤0.01% | 2486 |
|